The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Regulatory News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 63.50
Bid: 62.00
Ask: 65.00
Change: 1.00 (1.60%)
Spread: 3.00 (4.839%)
Open: 62.50
High: 63.50
Low: 62.50
Prev. Close: 62.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Posting of Circular

21 Oct 2015 13:52

RNS Number : 9468C
NetScientific PLC
21 October 2015
 

NetScientific plc

("NetScientific" or the "Company")

 

Posting of Circular

 

21 October 2015

 

Further to the announcement made by the Company on 1 October 2015, NetScientific announces that a Circular has today been published and posted to shareholders in relation to the proposed placing to raise approximately £18.0 million (before expenses), the additional fundraising to raise up to approximately £2.0 million, the proposed waiver of Rule 9 of The City Code on Takeovers and Mergers, and the notice of General Meeting. The General Meeting is due to be held at Simmons & Simmons, 1 Ropemaker Street, London EC2Y 9HT at 9.00 a.m. on 6 November 2015.

 

A copy of the Circular will shortly be made available on the Company's website at the following URL: www.netscientific.net/investors/aim-rule-26.

 

 

Expected timetable of events 

 

Latest time and date for receipt of completed Forms of Proxy to be valid at the General Meeting

 

 

9.00 a.m. on 4 November 2015

Additional Fundraising Close

11.00 a.m. on 5 November 2015

 

Admission and commencement of dealings in the New Ordinary Shares

 

8.00 a.m. on 9 November 2015

 

Placing Shares and Additional Fundraising Shares credited to CREST members' accounts (where applicable)

 

9 November 2015

 

Despatch of definitive share certificates for the New Ordinary Shares in certificated form (where appropriate)

 

 

within 10 days of Admission

   

 

Application will be made to the London Stock Exchange for the Admission of the new ordinary shares to trading on AIM. It is expected that Admission will occur and that dealings will commence at 8.00 a.m. on 9 November 2015.

 

Contact Details

 

NetScientific plc

 

François R. Martelet, M.D., CEO

Tel: +44 (0)20 3514 1800

Peter Thoms, CFO

 

 

 

Investec Bank plc (NOMAD, broker and joint bookrunner in connection with the placing)

Tel: +44 (0)20 7597 4000

Gary Clarence / Daniel Adams

 

 

 

Liberum Capital Limited (joint bookrunner in connection with the placing)

Tel: +44 (0)20 3100 2000

Christopher Britton

 

 

 

Instinctif Partners

Melanie Toyne-Sewell / Jayne Crook / Rosanna Forrest

Tel: +44 (0)20 7457 2020 ornetscientific@instinctif.com

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGIBDGRSDBGUB
Date   Source Headline
10th May 20249:12 amRNSPDS Biotech: Clinical trial meets study endpoints
15th Apr 20247:00 amRNSProAxsis secures c.£1.8mn investment
27th Mar 20241:34 pmRNSPDS Strategy Update and 2023 Financial Results
13th Mar 20247:00 amRNSBusiness Update
5th Feb 20247:00 amRNSExercise of Options and Issue of Shares
23rd Jan 20247:00 amRNSGlycotest secures $1 million investment
1st Dec 20237:00 amRNSDeepTech Recycling secures £1 million investment
14th Nov 20234:39 pmRNSPDS BioTechnology: Third Quarter Results
13th Nov 20237:00 amRNSDirector/PDMR Shareholding
9th Nov 20235:28 pmRNSPDS Biotech Announces Updated Survival Data
6th Nov 20237:00 amRNSVentive secures c.£900,000 investment
2nd Nov 20237:00 amRNSChange of Adviser
23rd Oct 20236:22 pmRNSPDS Preliminary Biomarker Study Results
13th Oct 20237:00 amRNSExercise of Options
3rd Oct 20234:12 pmRNSDirector/PDMR Shareholding
3rd Oct 20233:21 pmRNSPDS: Interim 24-month survival rate of 74% update
3rd Oct 20237:00 amRNSPDS Biotech: new data on PDS0101
28th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSQ-Bot: £3.5 million investment to drive expansion
14th Aug 20235:55 pmRNSPDS Biotech: 2nd Quarter Results, Business Update
14th Aug 20235:51 pmRNSPDS Biotech: Submission of Phase 3 Protocol to FDA
3rd Jul 20237:00 amRNSGrant of Options, Issue of Shares, Director/PDMR
30th Jun 20237:00 amRNSDName-iT Holdings Limited Fundraising
29th Jun 202311:04 amRNSResult of AGM & Board Changes
22nd Jun 20237:00 amRNSVortex Fundraising
14th Jun 20233:31 pmRNSPDS Announces Achievement of Efficacy Threshold
7th Jun 20237:00 amRNSDirector/PDMR Shareholding
6th Jun 20237:00 amRNSNotice of AGM
31st May 20237:01 amRNSPreliminary Results for the year ended 31 Dec 2022
31st May 20237:00 amRNSBoard Changes
26th May 20239:39 amRNSPDS Biotech Announces Interim Data
24th May 20237:00 amRNSSofant and Inmarsat announce joint development
15th May 20233:16 pmRNSPDS Business Update and First Quarter Results
2nd May 20237:00 amRNSGlycotest, Inc. Fundraising
3rd Apr 20237:00 amRNSBusiness Update
30th Mar 20233:51 pmRNSPDS Update
28th Mar 20233:50 pmRNSPDS Business Update and 2022 Financial Results
28th Feb 20237:00 amRNSRelated party loan to ProAxsis Limited
27th Feb 20233:28 pmRNSPDS completes FDA meeting for triple combination
10th Feb 20232:05 pmRNSSecond Price Monitoring Extn
10th Feb 20232:00 pmRNSPrice Monitoring Extension
10th Feb 202311:05 amRNSSecond Price Monitoring Extn
10th Feb 202311:00 amRNSPrice Monitoring Extension
1st Feb 20237:00 amRNSBoard Change
3rd Jan 20231:31 pmRNSPDS Announces Exclusive Global License Agreement
28th Dec 20223:05 pmRNSPDS Biotech: Median Overall Survival announcement
16th Dec 20227:00 amRNSPDS: HPV16 Head and Neck Cancer announcement
12th Dec 20222:00 pmRNSBoard Changes; Options; Co-Investment Agreement
29th Nov 20227:00 amRNSEMV C leads £4.2m round in 5G and SATCOM leader
14th Nov 20222:50 pmRNSPDS Q3 Results and Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.